Description
Niclochrist (Niclosamide) 500 mg
Niclochrist is identified by the supplied product name as a niclosamide 500 mg tablet. Niclosamide is an anthelmintic medicine used for intestinal tapeworm infections. The product name itself should still be confirmed against the local pack or official leaflet before use.
Active Ingredient and Medicine Class
Active ingredient: niclosamide.
Medicine class: anthelmintic, specifically an anti-cestode medicine. WHO essential-medicine listings include niclosamide 500 mg chewable tablets, reflecting its established place in treatment of intestinal tapeworm infection.
Established Medical Uses
Niclosamide has long been used for intestinal tapeworm infections, including common human cestodes. Reviews in PubMed describe it as a drug of choice for tapeworm infection treatment, with clinical use focused on intestinal cestodes rather than systemic parasitic disease.
How It Works
Niclosamide acts locally in the gut against tapeworms. Published reviews describe disruption of parasite energy metabolism, including uncoupling of oxidative phosphorylation, which deprives the worm of usable energy and helps stop its survival.
Important Safety Information
Important safety details vary by country and product, but niclosamide is generally treated as a medicine for intestinal infection only. It should not be assumed to be suitable for all worm infections. Published literature highlights that other antiparasitic agents may be preferred in some settings, and that tapeworm management can differ by species and clinical context.
Major clinically significant interactions and contraindications are not consistently presented in the accessible regulatory sources reviewed here for this specific brand, so they should be verified in the local official leaflet before use.
Possible Side Effects
Niclosamide has generally been described as relatively well tolerated in older clinical reviews, but gastrointestinal effects may occur. Reported adverse effects in the literature include nausea, abdominal discomfort, vomiting, and other mild digestive symptoms; serious reactions are uncommon in the sources reviewed, but complete safety information depends on the product label used locally.
Scientific Evidence
Human clinical literature supports niclosamide as an established treatment for intestinal tapeworm infections. Older reviews and comparative studies report clinical effectiveness against taeniasis and other cestode infections, while more recent systematic review work continues to evaluate its efficacy and safety in Taenia solium control programmes.
Medical Information Notice
This educational summary is based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified health professional.
